Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004367751 | SCV004854394 | uncertain significance | Inborn genetic diseases | 2023-11-29 | criteria provided, single submitter | clinical testing | The c.1291A>T (p.I431F) alteration is located in exon 8 (coding exon 8) of the CYP11B1 gene. This alteration results from a A to T substitution at nucleotide position 1291, causing the isoleucine (I) at amino acid position 431 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005040631 | SCV005675048 | uncertain significance | Deficiency of steroid 11-beta-monooxygenase; Glucocorticoid-remediable aldosteronism | 2024-05-07 | criteria provided, single submitter | clinical testing |